Activation of GPR30 Ameliorates Cerebral Ischemia–Reperfusion Injury by Suppressing Ferroptosis Through Nrf2/GPX4 Signaling Pathway
NeuroMolecular Medicine · 13.08.2024 · 26 (1)
DOI: 10.1007/s12017-024-08801-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift NeuroMolecular Medicine, online erschienen am 13.08.2024. Verfasst von Yong-Qiang Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Reperfusion Injury, Receptors, G-Protein-Coupled, Ferroptosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Key Research and Development Program in Shaanxi Province of China, This work was supported by the National Natural Science Foundation of China.
Abstract (Originalsprache)
The newly identified estrogen receptor, G protein-coupled receptor 30 (GPR30), is prevalent in the brain and has been shown to provide significant neuroprotection. Recent studies have linked ferroptosis, a newly characterized form of programmed cell death, closely with cerebral ischemia-reperfusion injury (CIRI), highlighting it as a major contributing factor. Consequently, our research aimed to explore the potential of GPR30 targeting in controlling neuronal ferroptosis and lessening CIRI impacts. Results indicated that GPR30 activation not only improved neurological outcomes and decreased infarct size in a mouse model but also lessened iron accumulation and malondialdehyde formation post-middle cerebral artery occlusion (MCAO). This protective effect extended to increased levels of Nrf2 and GPX4 proteins. Similar protective results were replicated in PC12 cells subjected to Oxygen Glucose Deprivation and Reoxygenation (OGD/R) using the GPR30-specific agonist G1. Importantly, inhibition of Nrf2 with ML385 curtailed the neuroprotective effects of GPR30 activation, suggesting that GPR30 mitigates CIRI primarily through inhibition of neuronal ferroptosis via upregulation of Nrf2 and GPX4.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
- Department of Chemistry, School of Pharmacy, Air Force Medical University, Xi'an, Shaanxi, China.
- Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China. anran1222@163.com.
- Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China. minggao@fmmu.edu.cn.
Förderung
- Key Research and Development Program in Shaanxi Province of China
- This work was supported by the National Natural Science Foundation of China
Zitieren
APA
Zhang, Y. Q., Sun, T., Zhao, Z., Fu, J., Yang, L., Xu, Y., Zhao, J. F., Tang, X. L., Liu, A., & Zhao, M. G. (2024). Activation of GPR30 Ameliorates Cerebral Ischemia–Reperfusion Injury by Suppressing Ferroptosis Through Nrf2/GPX4 Signaling Pathway. NeuroMolecular Medicine, 26(1). https://doi.org/10.1007/s12017-024-08801-5
Vancouver
Zhang YQ, Sun T, Zhao Z, Fu J, Yang L, Xu Y, et al. Activation of GPR30 Ameliorates Cerebral Ischemia–Reperfusion Injury by Suppressing Ferroptosis Through Nrf2/GPX4 Signaling Pathway. NeuroMolecular Medicine. 2024;26(1). doi:10.1007/s12017-024-08801-5
BibTeX
@article{Zhang2024,
author = {Zhang, Yong-Qiang and Sun, Ting and Zhao, Zhen and Fu, Jing and Yang, Le and Xu, Yuan and Zhao, Jing-Feng and Tang, Xiu-Ling and Liu, An and Zhao, Ming-Gao},
title = {Activation of GPR30 Ameliorates Cerebral Ischemia–Reperfusion Injury by Suppressing Ferroptosis Through Nrf2/GPX4 Signaling Pathway},
journal = {NeuroMolecular Medicine},
year = {2024},
volume = {26},
number = {1},
doi = {10.1007/s12017-024-08801-5}
}
EUVIMED